Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: An analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998

References

• Bacci G, Ferrari S, Bertoni F, Rimondini S, Longhi A, Bacchini P, et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Onco1 2000; 81: 4–11
   Google Scholar
• Gobel V, Jurgens H, Etspuler G, Kemperdick H, Junblut RM, Stienen U, et al. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents. J Cancer Res Clin Oncol 1987; 113: 187–91
   PubMed Web of Science ®Google Scholar
• Bacci G, Campanacci M, Pagani PA. Adjuvant chemotherapy in the treatment of clinically localised Ewing's sarcoma. J Bone Joint Surg [Br] 1978; 60: 567–74
   PubMedGoogle Scholar
• Bacci G, Toni A, Avella M, Manfrini M, Sudanese A, Ciaroni D, et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 1989; 63: 1477–86
   PubMed Web of Science ®Google Scholar
• Bacci G, Picci P, Ferrari S, Mercuri M, Brach del Prever A, Rosito P, et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: No benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase: Results of two sequential studies. Cancer 1998; 82: 1174–83
   PubMed Web of Science ®Google Scholar
• Bacci G, Mercuri M, Longhi A, Bertoni F, Barbieri E, Donati D, et al. Neoadjuvant chemotherapy for Ewing's tumour of bone: Recent experience at the Rizzoli Orthopaedic Institute. Eur J Cancer 2002; 38: 2243–51
   PubMed Web of Science ®Google Scholar
• Barbieri E, Frezza G, Martelli O, Neri S, Mercuri M, Gherlinzoni F, et al. Non conventional fractionation in radiotherapy of the musculo-skeletal sarcomas. Tumori 1998; 84: 167–70
   PubMed Web of Science ®Google Scholar
• Enneking W, Dunham W, Gebhardt M, Malawad M, Pritchard D. A system for the classification of skeletal resections. Chir Organi Mov 1990; 75: 217–40
   PubMedGoogle Scholar
• Picci P, Rougraff BT, Bacci G, Neff JR, Sangiorgi L, Cazzola A, et al. Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol 1993; 11: 1763–9
   PubMed Web of Science ®Google Scholar
• Paulussen M, Ahrens S, Dunst J, Winkelmann W, Exner GU, Kotz R, et al. Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001; 19: 1818–29
   PubMed Web of Science ®Google Scholar
• Delepine N, Delepine G, Cornille H, Voisin MC, Brun B, Desbois JC, et al. Prognostic factors in patients with localized Ewing's sarcoma: The effect on survival of actual received drug dose intensity and of histologic response to induction therapy. J Chemother 1997; 9: 352–63
   PubMed Web of Science ®Google Scholar
• Jurgens H, Exner U, Gadner H, Harms D, Michaelis J, Sauer R, et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial. Cancer 1988; 61: 23–32
   PubMed Web of Science ®Google Scholar
• Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18: 3108–14
   PubMed Web of Science ®Google Scholar
• Smeland S, Wiebe T, Brosjo O,Bohling, T Alvegard TA. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 2004;75:S87–S91 (Suppl).
   Web of Science ®Google Scholar
• Bacci G, Ferrari S, Longhi A, Rimondini S, Versari M, Zanone A, et al. Prognostic significance of serum LDH in Ewing's sarcoma of bone. Oncol Rep 1999; 6: 807–11
   PubMed Web of Science ®Google Scholar
• Farley FA, Healey JH, Caparros-Sison B, Godbold J, Lane JM, Glasser BD, et al. Lactase dehydrogenase as a tumor marker for recurrent disease in Ewing's sarcoma. Cancer 1987; 59: 1245–8
   PubMed Web of Science ®Google Scholar
• Gehan EA, Nesbit ME, Jr, Burgert EO, Jr, Burgert EO, Vietti J, Teft M, Perez CA, et al. Prognostic factors in children with Ewing's sarcoma. Natl Cancer Inst Monogr 1981; 56: 273–8
   Google Scholar
• Oberlin O, Deley MC, Bui BN, Gentet JC, Philip T, Terrier P, et al. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: The third study of the French Society of Paediatric Oncology (EW88 study). Br J Cancer 2001; 85: 1646–54
   PubMed Web of Science ®Google Scholar
• Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CI, Priychard DJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003; 348: 694–701
   PubMed Web of Science ®Google Scholar
• Ozaki T, Hillmann A, Hoffmann C, Rube C, Blasius S, Dunst J, et al. Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study. Cancer 1996; 78: 892–900
   PubMed Web of Science ®Google Scholar
• Dunst J, Jurgens H, Sauer R, Pape H, Paulussen M, Winkelkmann W, et al. Radiation therapy in Ewing's sarcoma: An update of the CESS 86 trial. Int J Radiat Oncol Biol Phys 1995; 32: 919–30
   PubMed Web of Science ®Google Scholar
• Burghert EO, Jr, Nesbit ME, Garnsey LA, Gehan EA, Herrmann J, Vietti TJ, et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup study IESS-II. J Clin Oncol 1990; 8: 1514–24
   PubMed Web of Science ®Google Scholar
• Oberlin O, Habrand JL. Ewing's sarcoma: Towards a common protocol for adults and children. Cancer Radiother 2000;4:S141–S144 (Suppl).
   Google Scholar